Authors:
KATSURA Y
ZHANG XY
HOMMA K
RICE KC
CALDERON SN
ROTHMAN RB
YAMAMURA HI
DAVIS P
FLIPPENANDERSON JL
XU H
BECKETTS K
FOLTZ EJ
PORRECA F
Citation: Y. Katsura et al., PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .25. SYNTHESIS AND EVALUATION OF N-ALKYL-SUBSTITUTED (ALPHA-PIPERAZINYLBENZYL)BENZAMIDES ASNOVEL, HIGHLY SELECTIVE DELTA-OPIOID RECEPTOR AGONISTS, Journal of medicinal chemistry, 40(18), 1997, pp. 2936-2947
Citation: Rb. Rothman et al., PHENTERMINE REDUCES COCAINE-INDUCED INCREASES IN BRAIN DA AND COCAINESELF-ADMINISTRATION, Biological psychiatry, 41, 1997, pp. 20-20
Authors:
STALEY JK
OUYANG Q
PABLO J
HEARN WL
FLYNN DD
ROTHMAN RB
RICE KC
MASH DC
Citation: Jk. Staley et al., PHARMACOLOGICAL SCREEN FOR ACTIVITIES OF 12-HYDROXYIBOGAMINE - A PRIMARY METABOLITE OF THE INDOLE ALKALOID IBOGAINE, Psychopharmacology, 127(1), 1996, pp. 10-18
Authors:
KAYAKIRI H
JACOBSON AE
RICE KC
ROTHMAN RB
XU H
FLIPPENANDERSON JL
GEORGE C
ACETO MD
BOWMAN ER
HARRIS LS
MAY EL
PARTILLA JS
BECKETTS K
Citation: H. Kayakiri et al., PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .24. SYNTHESIS, SINGLE-CRYSTAL X-RAY ANALYSES, IN-VITRO AND IN-VIVO PROPERTIES OF -3,14-DIHYDROXY-17-METHYL-4,5-ALPHA-EPOXYMORPHINAN AND -3,14-DIHYDROXY-17-METHYL-4,5-ALPHA-EPOXYMORPHINAN, Medicinal chemistry research, 6(6), 1996, pp. 427-438
Authors:
BRAUER LH
JOHANSON CE
SCHUSTER CR
ROTHMAN RB
DEWIT H
Citation: Lh. Brauer et al., EVALUATION OF PHENTERMINE AND FENFLURAMINE, ALONE AND IN COMBINATION,IN NORMAL, HEALTHY-VOLUNTEERS, Neuropsychopharmacology, 14(4), 1996, pp. 233-241
Citation: Mh. Baumann et al., EFFECTS OF PHENTERMINE AND COCAINE ON FENFLURAMINE-INDUCED DEPLETION OF SEROTONIN IN MOUSE-BRAIN, Drug and alcohol dependence, 41(1), 1996, pp. 71-74
Authors:
CALDERON SN
BERTHA CM
GUTKIND JS
XU H
PARTILLA JS
ROTHMAN RB
RICE KC
Citation: Sn. Calderon et al., PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .22. SYNTHESIS AND CHARACTERIZATION OF OPTICALLY PURE [H-3] IPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAMIDE, [H-3] SNC-121, A NOVEL HIGH-AFFINITY AND SELECTIVELIGAND FOR DELTA-OPIOID RECEPTORS()), Journal of labelled compounds & radiopharmaceuticals, 38(9), 1996, pp. 847-850
Authors:
GOODMAN CB
EMILIEN B
BECKETTS K
CADET JL
ROTHMAN RB
Citation: Cb. Goodman et al., DOWN-REGULATION OF MU-OPIOID BINDING-SITES FOLLOWING CHRONIC ADMINISTRATION OF NEUROPEPTIDE FF (NPFF) AND MORPHINE, Peptides, 17(3), 1996, pp. 389-397
Citation: Rb. Rothman, TREATMENT OF A 4-YEAR-OLD BOY WITH ADHD WITH THE DOPAMINE RELEASER PHENTERMINE, The Journal of clinical psychiatry, 57(7), 1996, pp. 308-309
Citation: Rb. Rothman, SMOKING CESSATION IN A PATIENT BEING TREATED WITH FENFLURAMINE PLUS PHENTERMINE FOR SIMPLE OBESITY, The Journal of clinical psychiatry, 57(2), 1996, pp. 92-93
Authors:
PICKWORTH WB
BAUMANN MH
FANT RV
ROTHMAN RB
HENNINGFIELD JE
Citation: Wb. Pickworth et al., ENDOCRINE RESPONSES DURING ACUTE NICOTINE WITHDRAWAL, Pharmacology, biochemistry and behavior, 55(3), 1996, pp. 433-437
Authors:
ELMER GI
BROCKINGTON A
GORELICK DA
CARROL FI
RICE KC
MATECKA D
GOLDBERG SR
ROTHMAN RB
Citation: Gi. Elmer et al., COCAINE CROSS-SENSITIZATION TO DOPAMINE UPTAKE INHIBITORS - UNIQUE EFFECTS OF GBR12909, Pharmacology, biochemistry and behavior, 53(4), 1996, pp. 911-918
Authors:
ELMER GI
GORELICK DA
GOLDBERG SR
ROTHMAN RB
Citation: Gi. Elmer et al., ACUTE SENSITIVITY VS CONTEXT-SPECIFIC SENSITIZATION TO COCAINE AS A FUNCTION OF GENOTYPE, Pharmacology, biochemistry and behavior, 53(3), 1996, pp. 623-628
Citation: Mh. Baumann et Rb. Rothman, CHRONIC COCAINE EXPOSURE POTENTIATES PROLACTIN AND HEAD SHAKE RESPONSES TO 5-HT2 RECEPTOR STIMULATION IN RATS, Neuropharmacology, 35(3), 1996, pp. 295-301
Authors:
STALEY JK
ROTHMAN RB
RICE KC
SANCHEZRAMOS J
WEINER WJ
MASH DC
Citation: Jk. Staley et al., MAPPING THE DISTRIBUTION OF KAPPA-2 OPIOID RECEPTORS IN PARKINSONS-DISEASE - A LIGAND-BINDING AND AUTORADIOGRAPHY STUDY, Neurology, 46(2), 1996, pp. 6049-6049
Authors:
KNAPP RJ
SANTORO G
DELEON IA
LEE KB
EDSALL SA
WAITE S
MALATYNSKA E
VARGA E
CALDERON SN
RICE KC
ROTHMAN RB
PORRECA F
ROESKE WR
YAMAMURA HI
Citation: Rj. Knapp et al., STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SNC80 AND RELATED-COMPOUNDS AT CLONED HUMAN DELTA-OPIOID AND MU-OPIOID RECEPTORS, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1284-1291
Authors:
BILSKY EJ
BERNSTEIN RN
HRUBY VJ
ROTHMAN RB
LAI J
PORRECA F
Citation: Ej. Bilsky et al., CHARACTERIZATION OF ANTINOCICEPTION TO OPIOID RECEPTOR-SELECTIVE AGONISTS AFTER ANTISENSE OLIGODEOXYNUCLEOTIDE-MEDIATED KNOCK-DOWN OF OPIOID RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 491-501
Authors:
GLOWA JR
FANTEGROSSI WE
LEWIS DB
MATECKA D
RICE KC
ROTHMAN RB
Citation: Jr. Glowa et al., SUSTAINED DECREASE IN COCAINE-MAINTAINED RESPONDING IN RHESUS-MONKEYSWITH HOXY]ETHYL]4-(3-HYDROXY-3-PHENYLPROPYL)PIPERAZINYL DECANOATE, A LONG-ACTING ESTER DERIVATIVE OF GBR-12909, Journal of medicinal chemistry, 39(24), 1996, pp. 4689-4691
Authors:
MATECKA D
ROTHMAN RB
RADESCA L
DECOSTA BR
DERSCH CM
PARTILLA JS
PERT A
GLOWA JR
WOJNICKI FHE
RICE KC
Citation: D. Matecka et al., DEVELOPMENT OF NOVEL, POTENT, AND SELECTIVE DOPAMINE REUPTAKE INHIBITORS THROUGH ALTERATION OF THE PIPERAZINE RING OF PHENYLMETHOXY)ETHYL]-4-(3-PHENYLPROPYL)PIPERAZINES AND HENYL)METHOXY]ETHYL]-4-(3-PHENYLPROPYL)PIPERAZINES (GBR-12935 AND GBR-12909), Journal of medicinal chemistry, 39(24), 1996, pp. 4704-4716
Authors:
BERTHA CM
ELLIS M
FLIPPENANDERSON JL
PORRECA F
ROTHMAN RB
DAVIS P
XU H
BECKETTS K
RICE KC
Citation: Cm. Bertha et al., PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .21. NOVEL DERIVATIVES OF L-2,6-METHANO-6H-AZOCINO[4,5-B]INDOL-6-YL)-PHENOLS WITH IMPROVED DELTA-OPIOID RECEPTOR SELECTIVITY, Journal of medicinal chemistry, 39(10), 1996, pp. 2081-2086